Corporate Performance

Corporate Performance Articles

Even in bear markets and recessions, some nimble companies either have incredibly resilient management teams or just happen to be in the right place at the right time.
COVID-19 has already beaten up tobacco giant Altria but things may be getting even worse as Juul, in which it has a stake, is facing fresh problems.
Beyond Meat hopes to gain a larger share of the market as beef prices rise because of production disruptions related to COVID-19.
The value of "The Last Dance," ESPN's 10-part Michael Jordan series, isn't lost on Nike, which features a trailer for the show on its website.
That last year was a terrible one for marijuana stocks is indisputable. So far, 2020 has not been much kinder, with Tilray shares down by more than 50% year to date. Yet, the company said it expects...
MicroVision is exploring strategic alternatives in an effort to maximize its shareholder value. Whether that is a sale of the company, a sale of some products or a venture remains to be seen.
Uber has run out of ways to attract riders while the spread of COVID-19 requires safety rules and social distancing. Revenue has collapsed.
A reverse stock split, collapsing bond prices and a never-ending weight of debt have combined to threaten Chesapeake Energy's ability to remain a going concern.
J.C. Penney is widely expected to seek bankruptcy protection as soon as this week.
Thanks to shelter-in-place orders around the globe, Facebook usage is way up. But the tech giant faces strong headwinds due to declines in advertising.
This Detroit automaker needs to get back on track, and the only way they can do that is by restarting production in a safe but effective way before it falls to penny stock status.
Analysts are optimistic about Nvidia ahead of earnings, based in part on its recent acquisition of Mellanox Technologies and its strong position in gaming.
Is Northrop Grumman stock immune to the coronavirus? Defense has historically been an attractive sector during economic downturns and the aerospace giant doesn’t expect major impacts from the...
Across the board, cruise companies were tossed around on Monday amid concerns that a potential second wave of coronavirus infections could stifle business.
This specialty pharmaceutical company is making good progress on multiple fronts, including changes to its board of directors and with its test for and treatment of COVID-19.